CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Fourth Annual JMP Securities Healthcare Focus Conference, being held October 5-6th at The New York Palace Hotel in New York City, NY. Mr. Christensen will present a corporate progress report, including an update on the Company’s clinical development programs. The Dyax presentation is scheduled for Monday, October 5th at 1:00 PM (ET).
